Novel antitumor antibiotics cochleamycins A, A2, B and B2 (Fig. 1) were isolated from the culture broth of Streptomyces sp. DTI36. They were purified by column chromatography on silica gel, reversed phase HPLCand then isolated as colorless powder. Cochleamycins showed growth inhibition against tumor cells in vitro.
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Novel antitumor antibiotics cochleamycins A, A2, B and B2 ( Fig. 1) were isolated from the culture broth of Streptomyces sp. DTI36. They were purified by column chromatography on silica gel, reversed phase HPLCand then isolated as colorless powder. Cochleamycins showed growth inhibition against tumor cells in vitro.
In the course of screening for new antitumor antibiotics, Streptomyces sp. DTI36 was found to produce novel antitumor antibiotics cochleamycins A, A2, B and B2. Cochleamycinswere recovered from the supernatant by EtOAc extraction and purified by chromatography. while B and B2 did not.
In 1992, we report the isolation, structure determination and biological activities ofcochleamycins A and B1}. In this paper, we report the taxonomy of the producing strain, and the production, isolation and biological activities of cochleamycins. Physico-chemical properties, structure determination and biosynthetic studies will be reported in the accompanying papers2'3).
Taxonomyof the Producing Strain
Strain DTI36 was isolated from a soil sample collected at Nishimeya-cho, Aomori Prefecture, Japan. Characterization of the strain was carried out mainly by the methods described by Shirling and Gottlieb3).
The aerial mycelium of the strain monopodially branched on the long main stem and terminated forming Tables 1 and 2 , respectively. The whole-cell hydrolysate contained the L,L isomer of diaminopimelic acid which corresponds to cell-wall type I4). MK-9 (H4) and MK-9 (H6) were detected as the components of menaquinones5). From the above characteristics, it was concluded that the strain belongs to the genus Streptomyces.
Producion and Isolation Strain DTI36 was inoculated in a 500-ml Erlenmeyer flask containing 100ml of the fermentation medium consisting of glucose 2.5%, soy bean meal 1.5%, dry yeast 0.2% and CaCO3 0.4%, the pH being adjusted to 7.2 before sterilization. The fermentation was carried out at 27°C for 5 days on a rotary shaker. The time course The isolation procedures of cochleamycins A, A2, B and B2 are summarized in Fig. 3 . After removal of the mycelium, the supernatant (5 liters) was extracted with EtOAc (5 liters) at pH 7. The organic layer was con- Table 3 . Cochleamycin A and A2 showed antimicrobial activity against Gram-positive bacteria as shownin Table   4 .
Experimental Cytotoxicity on Tumor Cells
Tumor cells were cultured in RPMI-1640 medium supplement with 2mML-glutamine, 50 U/ml penicillin, 50jUg/ml streptomycin and 10%heat-inactivated fetal calf serum (FCS). The cells at 5 x 104/ml were incubated with testing agents in a humidified atomosphere of 5% CO2in air at 37°C for 2 days. The cytotoxic activities were essentially measured according to an automated colorimetric assay based on the production of dark formazancrystals by living cells incubated with the tetrazolium salt MTT.The results are expressed as IC50 values which are concentrations of the drug that inhibit cell growth by 50%.
Antimicrobial Activity 243
The antimicrobial spectrum of cochleamycins were determined using 8mmpaper discs (Toyo Seisakusho Co., Ltd.) and Nutrient agar medium (Difco) for bacteria and Saburoud agar medium (Difco) for yeasts. Antimicrobial activity was observed after 24 hours incubation at 37°Cfor bacteria or longer incubation at 27°C for yeasts.
